Pharmacopsychosocial treatment of opioid dependence: Harm reduction, palliation, or simply good medical practice?

___

1. Koob GF, Le Moal M. Plasticity of reward neurocircuitry and the ‘dark side’ of drug addiction. Nat Neurosci 2005; 8:1442-1444.

2. Chen D, Liu F, Shang Q, Song X, Miao X, Wang Z. Association between polymorphisms of DRD2 and DRD4 and opioid dependence: Evidence from the current studies. Am J Med Genet B Neuropsychiatr Genet 2011; 156:661-670.

3. Weiss RD, Potter JS, Fiellin DA, Byrne M, Connery HS, Dickinson W, Gardin J, Griffin ML, Gourevitch MN, Haller DL, Hasson AL, Huang Z, Jacobs P, Kosinski AS, Lindblad R, McCance-Katz EF, Provost SE, Selzer J, Somoza EC, Sonne SC, Ling W. Adjunctive Counseling During Brief and Extended Buprenorphine-Naloxone Treatment for Prescription Opioid Dependence: A 2-Phase Randomized Controlled Trial. Arch Gen Psychiatry 2011; 68:1238- 1246.

4. CDC. CDC Grand Rounds: Prescription Drug Overdoses — a U.S. Epidemic. Morbidity and Mortality Weekly (MMWR) 61[01], 10-13. 1-13-0012.

5. Tetrault JM, Fiellin DA. Current and potential pharmacological treatment options for maintenance therapy in opioid-dependent individuals. Drugs 2012; 72:217-228.

6. Braden JB, Sullivan MD, Ray GT, Saunders K, Merrill J, Silverberg MJ, Rutter CM, Weisner C, Banta-Green C, Campbell C, Von Korff M. Trends in long-term opioid therapy for noncancer pain among persons with a history of depression. Gen Hosp Psychiatry 2009; 31:564-570.

7. Kleber HD. Methadone maintenance 4 decades later. JAMA 2008; 300:2303-2305.

8. DuPont RL, McLellan AT, Carr G, Gendel M, Skipper GE. How are addicted physicians treated? A national survey of physician health programs. J Subst Abuse Treat 2009; 37:1-7.

9. Taxman FS, Henderson CE, Belenko S. Organizational context, systems change, and adopting treatment delivery systems in the criminal justice system. Drug Alcohol Depend 2009; 103 (Supp. 1):1-6.

10. Ward J, Hall W, Mattick RP. Role of maintenance treatment in opioid dependence. The Lancet 1999; 353:221-226.

11. Khantzian EJ, Mack JE, Schatzberg AF. Heroin use as an attempt to cope: clinical observations. Am J Psychiatry 1974; 131:160-164.

12. Dackis C, O’Brien C. Neurobiology of addiction: treatment and public policy ramifications. Nat Neurosci 2005; 8:1431-1436.

13. Leshner AI. Addiction is a brain disease, and it matters. Science 1997; 278:45-47.

14. Volkow N, Baler R, Goldstein R. Addiction: Pulling at the neural threads of social behaviors. Neuron 2011; 69:599-602.

15. O’Brien CP. Anticraving medications for relapse prevention: a possible new class of psychoactive medications. Am J Psychiatry 2005; 162:1423-1431.

16. Papaleo F, Ghozland S, Ingallinesi M, Roberts AJ, Koob GF, Contarino A. Disruption of the CRF2 Receptor pathway decreases the somatic expression of opiate withdrawal. Neuropsychopharmacology 2008; 33:2878-2887.

17. Gastfriend DR. Intramuscular extended-release naltrexone: current evidence. Ann N Y Acad Sci 2011; 1216:144-166.

18. Oviedo-Joekes E, Brissette S, Marsh DC, Lauzon P, Guh D, Anis A, Schechter MT. Diacetylmorphine versus methadone for the treatment of opioid addiction. N Engl J Med 2009; 361:777-786.

19. Fudala PJ, Bridge TP, Herbert S, Williford WO, Chiang CN, Jones K, Collins J, Raisch D, Casadonte P, Goldsmith RJ, Ling W, Malkerneker U, McNicholas L, Renner J, Stine S, Tusel D. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. N Engl J Med 2003; 349:949-958.

20. Nunes EV, Levin FR. Treatment of co-occurring depression and substance dependence: using meta-analysis to guide clinical recommendations. Psychiatr Ann 2008; 38:730-738.

21. Martin PR, Weinberg BA, Bealer BK. Healing Addiction: An Integrated Pharmacopsychosocial Approach to Treatment. Hoboken, New Jersey: John Wiley & Sons Inc., 2007.

22. McLellan AT, Lewis DC, O’Brien CP, Kleber HD. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 2000; 284:1689-1695.

23. Hettema J, Steele J, Miller WR. Motivational interviewing. Annu Rev Clin Psychol 2004; 1:91-111.
Düşünen Adam - Psikiyatri ve Nörolojik Bilimler Dergisi-Cover
  • ISSN: 1018-8681
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 1984
  • Yayıncı: Kare Yayıncılık
Sayıdaki Diğer Makaleler

Detection of demografic and clinical risk factors associated with neuroleptic malignant syndrome: Evaluation of cases in the Turkish literature

Filiz ALKAN, Kürşat ALTINBAŞ

Pharmacopsychosocial treatment of opioid dependence: Harm reduction, palliation, or simply good medical practice?

Peter R. MARTİN, A.J. Reid FİNLAYSON

Exercise dependence and evaluations of psychopathological features

MEHMET ERDAL VARDAR, SELMA ARZU VARDAR, İLHAN TOKSÖZ, Necdet SÜT

Accuracy of wısc-r and raven standard progressive matrices tests in mathematical success of children with adhd

A. Şebnem SOYSAL ACAR, Seda TAN, Seçil ALDEMİR

Perindopril kullanımı sonrasında serum lityum düzeyinde yükselme: bir olgu bildirimi

Filiz ALKAN BAYLAN, Kürşat ALTINBAŞ

Parkinson hastalığı ve delüzyonel parazitoz birlikteliği: Bir olgu sunumu

Emrullah GENÇ, SEMİHA GÜLSÜM KURT, Hatice ÜNALDI KARAER, Çam Feryal ÇELİKEL, Serap ERDOĞAN ÇİMEN

Polypharmacy among inpatients of a university psychiatry clinic: A retrospective study

Çınar YENİLMEZ, GÜLCAN GÜLEÇ, Alev BÜYÜKKINACI, Ali DAYI, Hülya Turgut, Yasemin ULUDAĞ TEKİN, Sevil AKBABA

The reliability and validity study of psychological screening test for adolescents

Kültegin ÖGEL, Gülşah KARADAYI, Gülçin ŞENYUVA, Habil KANOĞLU

Bir olgu sunumu eşliğinde rem uykusu davranış bozukluğuna bağlı suç işleme ve suçun adli psikiyatrik olarak değerlendirilmesi

F. Süheyla ALİUSTAOĞLU, Gökşen YÜKSEL, Sefa SAYGILI, Gökhan ORAL

Maintanence Treatment in opioid dependency

FATMA YEŞİM CAN, ELİF MUTLU, Vahap KARABULUT, Arzu DEMİRCİ ÇİFTÇİ, Gökhan UMUT, Turan ÇETİN